PERIPHERAL DOPAMINERGIC BLOCKADE FOR THE TREATMENT OF DIABETIC ORTHOSTATIC HYPOTENSION

被引：17

作者：

DEFARIA, SRGFL ^{[1
]}

ZANELLA, MT ^{[1
]}

ANDRIOLO, A ^{[1
]}

RIBEIRO, AB ^{[1
]}

CHACRA, AR ^{[1
]}

机构：

[1] ESCOLA PAULISTA MED,DIV ENDOCRINOL,RUA BOTUCATU 740,CAIXA POSTAL 20.266,BR-04023 SAO PAULO,SP,BRAZIL

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1988年 / 44卷 / 06期

关键词：

D O I：

10.1038/clpt.1988.210

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：670 / 674

页数：5

共 17 条

[1] DOPAMINE AS A POST-GANGLIONIC AUTONOMIC NEUROTRANSMITTER [J].

BELL, C .

NEUROSCIENCE, 1982, 7 (01) :1-8

[2] METOCLOPRAMIDE ALONE OR COMBINED WITH FLURBIPROFEN IN THE TREATMENT OF ORTHOSTATIC HYPOTENSION ASSOCIATED WITH DIABETES-MELLITUS [J].

BERETTAPICCOLI, C ;

WEIDMANN, P .

KLINISCHE WOCHENSCHRIFT, 1982, 60 (16) :863-865

[3] ACUTE HEMODYNAMIC AND HUMORAL EFFECTS OF METOCLOPRAMIDE ON BLOOD-PRESSURE CONTROL IMPROVEMENT IN SUBJECTS WITH DIABETIC ORTHOSTATIC HYPOTENSION [J].

BESSA, AM ;

ZANELLA, MT ;

SARAGOCA, MA ;

MULINARI, RA ;

CZEPIELEWSKI, M ;

RIBEIRO, AB ;

RAMOS, OL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (06) :738-744

[4] THE HYPERTENSIONS OF DIABETES [J].

CHRISTLIEB, AR .

DIABETES CARE, 1982, 5 (01) :50-58

[5] RECIPROCAL INFLUENCE OF SALT INTAKE ON ADRENAL GLOMERULOSA AND RENAL VASCULAR-RESPONSES TO ANGIOTENSIN-II IN NORMAL MAN [J].

HOLLENBERG, NK ;

CHENITZ, WR ;

ADAMS, DF ;

WILLIAMS, GH .

JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (01) :34-42

[6] SELECTIVE DA2 VERSUS DA1 ANTAGONIST ACTIVITY OF DOMPERIDONE IN THE PERIPHERY [J].

KOHLI, JD ;

GLOCK, D ;

GOLDBERG, LI .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 89 (1-2) :137-141

[7] ORTHOSTATIC HYPOTENSION - A POSTURE-INDUCED HYPERDOPAMINERGIC STATE [J].

KUCHEL, O ;

BUU, NT ;

HAMET, P ;

LAROCHELLE, P ;

GUTKOWSKA, J ;

SCHIFFRIN, EL ;

BOURQUE, M ;

GENEST, J .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1985, 289 (01) :3-11

[8] SIMPLE RADIOIMMUNOASSAY FOR URINARY ALDOSTERONE [J].

LANGAN, J ;

JACKSON, R ;

ADLIN, EV ;

CHANNICK, BJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 38 (02) :189-193

[9]

LANGER SZ, 1981, PHARMACOL REV, V32, P337

[10]

LAUDRON PM, 1979, BIOCHEM PHARMACOL, V28, P2161

← 1 2 →